TP53 and lung adenocarcinoma: Patients with TP53-mutated lung adenocarcinoma were characterized by a significant increased expression of PD-L1 (p < 0.05) and TMB (p < 0.001), and a higher tumor infiltration by CD8 + T cells (p < 0.05).